Cite
HARVARD Citation
Topp, M. et al. (2021). Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia: Results of a pooled analysis. Cancer medicine. pp. 2601-2610. [Online].